Evidence map›Paper›PMID 35313357›Full record

ArticleClinical oral investigations2022

Salivary levels of hBDs in children and adolescents with type 1 diabetes mellitus and gingivitis.

Dogukan Yilmaz, Neslihan Yilmaz, Recep Polat, Verneri Nissilä, Elif Gül Aydın, Jaana Rautava, Mervi Gürsoy, Ulvi Kahraman Gürsoy

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical oral investigations, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Dogukan YilmazDepartment of Periodontology, Faculty of Dentistry, Sakarya University, Sakarya, Turkey. dogukanyilmaz@sakarya.edu.tr.ORCID http://orcid.org/0000-0003-2576-0885
Neslihan YilmazDepartment of Pediatric Dentistry, Faculty of Dentistry, Sakarya University, Sakarya, Turkey.ORCID http://orcid.org/0000-0001-7939-9525
Recep PolatDepartment of Pediatric Endocrinology, Faculty of Medicine, Sakarya University, Sakarya, Turkey.ORCID http://orcid.org/0000-0002-3786-0739
Verneri NissiläDepartment of Periodontology, Institute of Dentistry, University of Turku, Turku, Finland.
Elif Gül AydınDepartment of Pediatric Dentistry, Faculty of Dentistry, Sakarya University, Sakarya, Turkey.
Jaana RautavaDepartment of Oral and Maxillofacial Diseases, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, ClinicumHelsinki, Finland.ORCID http://orcid.org/0000-0001-9946-2974
Mervi GürsoyDepartment of Periodontology, Institute of Dentistry, University of Turku, Turku, Finland.ORCID http://orcid.org/0000-0001-8545-6821
Ulvi Kahraman GürsoyDepartment of Periodontology, Institute of Dentistry, University of Turku, Turku, Finland.ORCID http://orcid.org/0000-0002-1225-5751
Sakarya University · TRUniversity of Turku · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesType 1 diabetes mellitus (T1DM), a chronic autoimmune disease characterized by insulin deficiency, is related to periodontal diseases in children and adolescents. Our aim was to profile salivary human beta-defensin (hBD)-2 and hBD-3 concentrations in relation to periodontal and T1DM status in children and adolescent populations. MATERIAL AND

methodsUnstimulated saliva samples were collected from 66 participants including periodontally healthy T1DM patients (T1DM + C; n = 18), T1DM patients with gingivitis (T1DM + G; n = 20), systemically and periodontally healthy individuals (SH + C: n = 15), and systemically healthy gingivitis patients (SH + G; n = 13). Full mouth plaque index (PI), bleeding on probing (BOP), probing pocket depth (PPD), and clinical attachment level (CAL) were recorded. Salivary hBD-2 and hBD-3 concentrations were evaluated by sandwich ELISA method. A p value of < 0.05 was considered statistically significant.

resultsSalivary hBD-3 concentrations were lower in T1DM groups in comparison to systemically healthy counterparts (SH + G vs. T1DM + G; p < 0.001 and SH + C vs. T1DM + C; p < 0.001). Salivary hBD-2 levels did not differ between related groups. The difference in hBD-3 concentrations between T1DM and control groups was still significant (p = 0.008) after being adjusted for PI%, BOP%, and age.

conclusionIn the limits of study, T1DM patients were found to have decreased salivary hBD-3 concentrations, regardless of their gingival inflammatory status. CLINICAL RELEVANCE: Altered salivary hBD-3 concentration can partly explain why diabetic children are more prone to periodontal diseases.

Indexed as

Diabetes Mellitus, Type 1GingivitisAdolescentChildGingival Crevicular FluidHumansSalivaAntimicrobialGingivitisSalivaType 1 diabetes mellitus

Identifiers

PMID35313357
OpenAlexW4220949824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.